Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Therapeutic peptides: current applications and future directions
The obesity epidemic: GLP-1 and its multiple effects are game-changers Though in existence since 2005, for patients, the GLP-1 receptor agonist medication class has a range of efficacy in different people
Semaglutide - For Patients Warning: There Is a Risk of Thyroid C-Cell Tumors
Others worried about the potential long-term risks of GLP-1s, which could require lifelong use given that weight usually returns when treatment ends
Patients with MEN 2 syndrome warrant particular attention, as this hereditary condition predisposes to MTC, pheochromocytoma, and parathyroid adenomas
US$ 20.02
US$ 23.50
US$ 27.50
US$ 22.53
US$ 27.91
